I think this bodes well for INNL. INNL is providing Phase 3 top line data for Diabetic foot ulcer infection next month. Phase 2 results look very good in my opinion.
However today INNL went down due to DPRX failure.
Please do your own due diligence. My post is for information only.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.